In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer.

Galal S, Chaltel Lima L, Wang N, Moury C, Yan G, Dai M, Ali S, Lebrun JJ

Open source

DOI
10.1038/s41467-026-76293-x
Published
2026 Aug 4
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-76293-x,
  title = {In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer.},
  author = {Galal S and Chaltel Lima L and Wang N and Moury C and Yan G and Dai M and Ali S and Lebrun JJ},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-76293-x},
  url = {https://doi.org/10.1038/s41467-026-76293-x}
}

RIS

TY  - JOUR
TI  - In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer.
AU  - Galal S
AU  - Chaltel Lima L
AU  - Wang N
AU  - Moury C
AU  - Yan G
AU  - Dai M
AU  - Ali S
AU  - Lebrun JJ
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-76293-x
UR  - https://doi.org/10.1038/s41467-026-76293-x
ER  - 

APA

S, G., L, C. L., N, W., C, M., G, Y., M, D., S, A., & JJ, L. (2026). In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer.. Nature communications. https://doi.org/10.1038/s41467-026-76293-x

Source records